Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

NEW YORK — The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, particularly in drug discovery and development. Dotmatics, a company ...

Insilico Medicine achieved an R&D collaboration with Servier valued at up to US$888 million, focused on discovering and developing innovative oncology therapies, by combining Insilico's AI-driven drug ...

Few healthcare endeavors are more daunting or resource intensive than the development of a new drug therapy. On average, it takes 10 to 12 years and millions of dollars for a new drug to be developed ...

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could revolutionize the drug industry. The safer, cheaper, more environmentally friendly ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Creating a new drug involves significant time, effort, and resources. Many assume drug development is straightforward, with final products approved fairly quickly, but the drug approval timeline can ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

For the past several years, investors have flocked to biotech on the promise of AI to accelerate drug development, reduce costs and enhance predictability. The math was a no-brainer: Shaving just 10% ...

A secretive lab within Alphabet, the parent company of Google, is on the verge of testing its first human clinical trials for cancer drugs designed entirely by artificial intelligence. Isomorphic Labs ...